Previous 10 | Next 10 |
2023-11-15 05:20:00 ET Wall Street traders have numerous (and often creative) strategies to speculate on stocks and their up and down price movements. There are times when the prices of stocks are influenced more by what these traders do rather than by the company's business operations. One...
2023-11-14 07:58:00 ET Summary Novavax's Q3 earnings call provided extensive guidance and business review. It finds itself in the unfortunate position of having heavily invested to serve a market which is rapidly shrinking. Novavax's prospects to build a successful business el...
2023-11-13 17:37:48 ET Summary Novavax, Inc. reported Q3 2023 numbers above consensus estimates based almost solely on grant revenue. The company cut guidance for 2023 revenues and even pushed out a large portion of those revenues to Q1 2024 due to weak COVID vaccine demand. T...
2023-11-09 16:59:04 ET Gainers: SMART Global Holdings ( SGH ) +-44% . Belden ( BDC ) +-25% . Bitdeer Technologies Holding ( BTDR ) +-20% . NextPlat ( NXPL ) +-12% . Voxeljet ( VJET ) +-10% . Losers: Mode...
2023-11-09 14:04:06 ET Novavax, Inc. (NVAX) Q3 2023 Earnings Conference Call November 9, 2023 08:30 AM ET Company Participants Erika Schultz - Senior Director, IR John Jacob - President & CEO John Trizzino - Chief Commercial Officer & Chief Business Offic...
2023-11-09 09:07:00 ET U.S. stock index futures on Thursday pointed to a marginally higher open, amid a week that has largely seen small moves in equities in light of a dearth of economic data. The third quarter earnings season continued to garner a chunk of attention, with Walt Disney ...
2023-11-09 08:30:31 ET COVID-19 vaccine maker Novavax ( NASDAQ: NVAX ) reported better than expected financials for Q3 2023 on Thursday as its grants from the U.S. government reached $164.9M, marking ~55% growth from last year due mainly to support activities and milestones. How...
2023-11-09 08:04:40 ET More on Novavax Moderna Vs. Novavax: Neither Offering Short-Term Value As Fall Vaccine Season Begins Novavax's COVID-19 Investment Thesis Is Old News Novavax COVID vaccine in focus ahead of Q3 earnings For further details see: Novav...
Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights PR Newswire Received authorization from the U.S. FDA and approval from the European Commission for the Company's updated COVID-19 vaccine, and launched the only protein-based non-mRNA vaccine opt...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
News, Short Squeeze, Breakout and More Instantly...
Novavax Submits Application to Health Canada for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine Canada NewsWire Novavax's COVID-19 vaccine would be the only protein-based option available in Canada , if authorized Novavax's filing is aligned with NACI, ...